Can AI Drive Peloton’s Comeback?

We discuss Pfizer’s $10 billion deal to buy Metsera and finally get into weight loss. Plus, Peloton is making a compeback and Circle is growing on the back of stablecoins, but Coinbase may be the real winner here. Travis Hoium, Rachel Warren, and Jon Quast discuss: - Pfizer buying Metsera - Peloton’s comeback - Circle’s growth and why Coinbase is a winner Companies discussed: Pfizer (PFE), Peloton (PTON), Circle (CRCL), Coinbase (COIN). Host: Travis Hoium Guests: Rachel Warren, Jon Quast Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity present...